Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Borrill

Showing results (121-130 of 163) with videos related to

Pageof 17
Sort By:
Pediatric Transplantation|December 30, 2014
In vivo T-cell depletion using alemtuzumab in family and unrelated donor transplantation for pediatric non-malignant disease achieves engraftment with low incidence of graft vs. host diseaseM A Saif, R Borrill, B W Bigger, et al.
MDM Policy & Practice|March 31, 2022
Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced MelanomaVictoria Federico Paly, Murat Kurt, Lirong Zhang, et al.
Developmental Cell|June 24, 2025
Exploring the diversity of plant model organismsAndrew R G Plackett, John L Bowman, Michael T Raissig, et al.
Genome Biology|August 18, 2018
Impact of transposable elements on genome structure and evolution in bread wheatThomas Wicker, Heidrun Gundlach, Manuel Spannagl, et al.
Journal for Immunotherapy of Cancer|July 15, 2020
Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspectiveCasey Quinn, Louis P Garrison, Anja K Pownell, et al.
BMJ Open|June 3, 2021
Acceptance and commitment therapy for young brain tumour survivors: study protocol for an acceptability and feasibility trialSam Malins, Ray Owen, Ingram Wright, et al.
Clinical Medicine (London, England)|November 7, 2003
A confidential study of deaths after emergency medical admission: issues relating to quality of careE Seward, E Greig, S Preston, et al.
Bone Marrow Transplantation|February 13, 2024
Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantationGiovanna Melica, Elaina Preston, Meighan Palazzo, et al.
Blood Advances|January 15, 2020
Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulinIoannis Politikos, Jessica A Lavery, Patrick Hilden, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2022
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer ImmunotherapiesStephen Palmer, Isabelle Borget, Tim Friede, et al.
Pageof 17

Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
Pediatric Transplantation|December 30, 2014
In vivo T-cell depletion using alemtuzumab in family and unrelated donor transplantation for pediatric non-malignant disease achieves engraftment with low incidence of graft vs. host diseaseM A Saif, R Borrill, B W Bigger, et al.
MDM Policy & Practice|March 31, 2022
Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced MelanomaVictoria Federico Paly, Murat Kurt, Lirong Zhang, et al.
Developmental Cell|June 24, 2025
Exploring the diversity of plant model organismsAndrew R G Plackett, John L Bowman, Michael T Raissig, et al.
Genome Biology|August 18, 2018
Impact of transposable elements on genome structure and evolution in bread wheatThomas Wicker, Heidrun Gundlach, Manuel Spannagl, et al.
Journal for Immunotherapy of Cancer|July 15, 2020
Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspectiveCasey Quinn, Louis P Garrison, Anja K Pownell, et al.
BMJ Open|June 3, 2021
Acceptance and commitment therapy for young brain tumour survivors: study protocol for an acceptability and feasibility trialSam Malins, Ray Owen, Ingram Wright, et al.
Clinical Medicine (London, England)|November 7, 2003
A confidential study of deaths after emergency medical admission: issues relating to quality of careE Seward, E Greig, S Preston, et al.
Bone Marrow Transplantation|February 13, 2024
Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantationGiovanna Melica, Elaina Preston, Meighan Palazzo, et al.
Blood Advances|January 15, 2020
Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulinIoannis Politikos, Jessica A Lavery, Patrick Hilden, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2022
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer ImmunotherapiesStephen Palmer, Isabelle Borget, Tim Friede, et al.
Pageof 17